Recruitment of sexual minority and heterosexual colorectal cancer survivors through US cancer registries.
Colorectal neoplasms
Recruitment
Registries
Sexual minority
Survivors
Journal
Journal of cancer survivorship : research and practice
ISSN: 1932-2267
Titre abrégé: J Cancer Surviv
Pays: United States
ID NLM: 101307557
Informations de publication
Date de publication:
25 Feb 2023
25 Feb 2023
Historique:
received:
12
10
2022
accepted:
25
01
2023
entrez:
25
2
2023
pubmed:
26
2
2023
medline:
26
2
2023
Statut:
aheadofprint
Résumé
Describe the process, outcomes, and costs of cancer registry recruitment and enrollment of sexual minority and heterosexual non-metastatic colorectal cancer survivors into an observational survivorship study. We recruited stage I-III colorectal cancer survivors from four US cancer registries. Potential participants were screened for eligibility, and all eligible sexual minority and every 10th heterosexual survivor was invited to participate in a 45-min telephone interview. We mailed study packets to 17,855 individuals and obtained 6370 screening surveys of presumed eligible individuals. After screening, there were 182 eligible sexual minority and 5568 eligible heterosexual survivors. Of the 719 invited survivors, 127 sexual minority and 353 heterosexual individuals participated in the interview. There were some small differences in personal and neighborhood sociodemographic characteristics for the survivors who screened eligible and completed the interview relative to the registry sample. The per-participant direct costs were about $40, $120, and $1425 in the registry, screened eligible, and interviewed samples, respectively. Although we did not observe substantial selection biases, the costs of enrolling a representative sample were high. Inclusion of sexual orientation and gender identity as standard demographic questions in cancer registries is needed for reliable and cost-efficient monitoring of population health.
Identifiants
pubmed: 36840834
doi: 10.1007/s11764-023-01343-y
pii: 10.1007/s11764-023-01343-y
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : National Cancer Institute, National Institutes of Health
ID : 1R01CA181392-01A1
Organisme : National Cancer Institute, National Institutes of Health
ID : 1R01CA181392-01A1
Organisme : National Cancer Institute, National Institutes of Health
ID : 1R01CA181392-01A1
Organisme : National Cancer Institute, National Institutes of Health
ID : 1R01CA181392-01A1
Organisme : National Cancer Institute, National Institutes of Health
ID : 1R01CA181392-01A1
Informations de copyright
© 2023. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Références
American Cancer Society. Cancer facts & figures 2022. www.cancer.org/content/dam/cancer-org/research/cancer-facts-and-statistics/annual-cancer-facts-and-figures/2022/2022-cancer-facts-and-figures.pdf . Accessed August 19, 2022.
Hewitt M, Greenfield S, Stovall E, editors. From cancer patient to cancer survivor: lost in transition. Washington, DC, USA: National Academies Press; 2006.
Salz T, Oeffinger KC, McCabe MS, Layne TM, Bach PB. Survivorship care plans in research and practice. CA: Cancer J Clin. 2012;62(2):101–17. https://doi.org/10.3322/caac.20142:10.3322/caac.20142 .
doi: 10.3322/caac.20142:10.3322/caac.20142
pubmed: 22241452
Denlinger CS, Barsevick AM. The challenges of colorectal cancer survivorship. J Natl Compr Canc Netw. 2009;7(8):883–93. https://doi.org/10.6004/jnccn.2009.0058:10.6004/jnccn.2009.0058 .
doi: 10.6004/jnccn.2009.0058:10.6004/jnccn.2009.0058
pubmed: 19755048
pmcid: 3110673
Valdivieso M, Kujawa AM, Jones T, Baker LH. Cancer survivors in the United States: a review of the literature and a call to action. Int J Med Sci. 2012;9(2):163–73. https://doi.org/10.7150/ijms.3827:10.7150/ijms.3827 .
doi: 10.7150/ijms.3827:10.7150/ijms.3827
pubmed: 22275855
pmcid: 3264952
Boyes AW, Girgis A, D’Este C, Zucca AC. Prevalence and correlates of cancer survivors’ supportive care needs 6 months after diagnosis: a population-based cross-sectional study. BMC Cancer. 2012;12:150. https://doi.org/10.1186/1471-2407-12-150:10.1186/1471-2407-12-150 .
doi: 10.1186/1471-2407-12-150:10.1186/1471-2407-12-150
pubmed: 22510387
pmcid: 3430551
National Academies of Sciences, Engineering, and Medicine. Understanding the well-being of LGBTQI+ populations. Patterson CJ, Sepúlveda M-J, White J, Editors. Washington, DC: The National Academies Press; 2020.
Pérez-Stable E. Sexual and gender minorities formally designated as a health disparity population for research purposes 2016 [updated June 27, 2022]. Available from: https://www.nimhd.nih.gov/about/directors-corner/messages/message_10-06-16.html . Accessed August 18, 2022.
Conron K, Goldberg, SK Adult LGBT population in the United States, July 2020. https://williamsinstitute.law.ucla.edu/wp-content/uploads/LGBT-Adult-US-Pop-Jul-2020.pdf . Accessed August 19, 2022.
Jones J. LGBT identification in U.S. ticks up to 7.1%, 2022. https://news.gallup.com/poll/389792/lgbt-identification-ticks-up.aspx . Accessed August 18, 2022.
National Cancer Institute, Division of Cancer Control and Population Sciences. Statistics and graphs, 2022. https://cancercontrol.cancer.gov/ocs/statistics#stats . Accessed September 16, 2022.
Gordon JR, Baik SH, Schwartz KTG, Wells KJ. Comparing the mental health of sexual minority and heterosexual cancer survivors: a systematic review. LGBT Health. 2019;6(6):271–88. https://doi.org/10.1089/lgbt.2018.0204:10.1089/lgbt.2018.0204 .
doi: 10.1089/lgbt.2018.0204:10.1089/lgbt.2018.0204
pubmed: 31314662
pmcid: 6740153
Kent EE, Wheldon CW, Smith AW, Srinivasan S, Geiger AM. Care delivery, patient experiences, and health outcomes among sexual and gender minority patients with cancer and survivors: a scoping review. Cancer. 2019;125(24):4371–9. https://doi.org/10.1002/cncr.32388:10.1002/cncr.32388 .
doi: 10.1002/cncr.32388:10.1002/cncr.32388
pubmed: 31593319
Pratt-Chapman ML, Alpert AB, Castillo DA. Health outcomes of sexual and gender minorities after cancer: a systematic review. Syst Rev. 2021;10(1):183. https://doi.org/10.1186/s13643-021-01707-4:10.1186/s13643-021-01707-4 .
doi: 10.1186/s13643-021-01707-4:10.1186/s13643-021-01707-4
pubmed: 34154645
pmcid: 8218456
Boehmer U, Gereige J, Winter M, Ozonoff A. Cancer survivors’ access to care and quality of life: do sexual minorities fare worse than heterosexuals? Cancer. 2019;125(17):3079–85. https://doi.org/10.1002/cncr.32151:10.1002/cncr.32151 .
doi: 10.1002/cncr.32151:10.1002/cncr.32151
pubmed: 31106409
Boehmer U, Miao X, Ozonoff A. Cancer survivorship and sexual orientation. Cancer. 2011;117(16):3796–804. https://doi.org/10.1002/cncr.25950:10.1002/cncr.25950 .
doi: 10.1002/cncr.25950:10.1002/cncr.25950
pubmed: 21557209
Boehmer U, Miao X, Ozonoff A. Health behaviors of cancer survivors of different sexual orientations. Cancer Causes Control. 2012;23(9):1489–96. https://doi.org/10.1007/s10552-012-0023-x:10.1007/s10552-012-0023-x .
doi: 10.1007/s10552-012-0023-x:10.1007/s10552-012-0023-x
pubmed: 22752329
Boehmer U, Ozonoff A, Miao X. An ecological analysis of colorectal cancer incidence and mortality: differences by sexual orientation. BMC Cancer. 2011;11:400. https://doi.org/10.1186/1471-2407-11-400:10.1186/1471-2407-11-400 .
doi: 10.1186/1471-2407-11-400:10.1186/1471-2407-11-400
pubmed: 21936932
pmcid: 3188512
Kamen C, Mustian KM, Dozier A, Bowen DJ, Li Y. Disparities in psychological distress impacting lesbian, gay, bisexual and transgender cancer survivors. Psychooncology. 2015;24(11):1384–91. https://doi.org/10.1002/pon.3746:10.1002/pon.3746 .
doi: 10.1002/pon.3746:10.1002/pon.3746
pubmed: 25630987
pmcid: 4517981
Kamen C, Palesh O, Gerry AA, Andrykowski MA, Heckler C, Mohile S, et al. Disparities in health risk behavior and psychological distress among gay versus heterosexual male cancer survivors. LGBT Health. 2014;1(2):86–92. https://doi.org/10.1089/lgbt.2013.0022:10.1089/lgbt.2013.0022 .
doi: 10.1089/lgbt.2013.0022:10.1089/lgbt.2013.0022
pubmed: 26789618
Quinn GP, Schabath MB, Sanchez JA, Sutton SK, Green BL. The importance of disclosure: lesbian, gay, bisexual, transgender/transsexual, queer/questioning, and intersex individuals and the cancer continuum. Cancer. 2015;121(8):1160–3. https://doi.org/10.1002/cncr.29203:10.1002/cncr.29203 .
doi: 10.1002/cncr.29203:10.1002/cncr.29203
pubmed: 25521303
Beskow LM, Sandler RS, Weinberger M. Research recruitment through us central cancer registries: balancing privacy and scientific issues. Am J Public Health. 2006;96(11):1920–6. https://doi.org/10.2105/AJPH.2004.061556:10.2105/AJPH.2004.061556 .
doi: 10.2105/AJPH.2004.061556:10.2105/AJPH.2004.061556
pubmed: 16571700
pmcid: 1751818
Pakilit AT, Kahn BA, Petersen L, Abraham LS, Greendale GA, Ganz PA. Making effective use of tumor registries for cancer survivorship research. Cancer. 2001;92(5):1305–14. https://doi.org/10.1002/1097-0142(20010901)92:5%3c1305::aid-cncr1452%3e3.0.co;2-m:10.1002/1097-0142(20010901)92:5%3c1305::aid-cncr1452%3e3.0.co;2-m .
doi: 10.1002/1097-0142(20010901)92:5<1305::aid-cncr1452>3.0.co;2-m:10.1002/1097-0142(20010901)92:5<1305::aid-cncr1452>3.0.co;2-m
pubmed: 11571747
Tucker TC, Durbin EB, McDowell JK, Huang B. Unlocking the potential of population-based cancer registries. Cancer. 2019;125(21):3729–37. https://doi.org/10.1002/cncr.32355:10.1002/cncr.32355 .
doi: 10.1002/cncr.32355:10.1002/cncr.32355
pubmed: 31381143
Bowen DJ, Boehmer U. The lack of cancer surveillance data on sexual minorities and strategies for change. Cancer Causes Control. 2007;18(4):343–9. https://doi.org/10.1007/s10552-007-0115-1 .
doi: 10.1007/s10552-007-0115-1
pubmed: 17325829
Gomez SL, Duffy C, Griggs JJ, John EM. Surveillance of cancer among sexual and gender minority populations: where are we and where do we need to go? Cancer. 2019;125(24):4360–2. https://doi.org/10.1002/cncr.32384:10.1002/cncr.32384 .
doi: 10.1002/cncr.32384:10.1002/cncr.32384
pubmed: 31593334
Cahill S, Singal R, Grasso C, King D, Mayer K, Baker K, et al. Do ask do tell: high levels of acceptability by patients of routine collection of sexual orientation and gender identity data in four diverse American community health centers. PloS One. 2014;9(9):e107104. https://doi.org/10.1371/journal.pone.0107104:10.1371/journal.pone.0107104 .
doi: 10.1371/journal.pone.0107104:10.1371/journal.pone.0107104
pubmed: 25198577
pmcid: 4157837
Bjarnadottir RI, Bockting W, Dowding DW. Patient perspectives on answering questions about sexual orientation and gender identity: an integrative review. J Clin Nurs. 2017;26(13–14):1814–33. https://doi.org/10.1111/jocn.13612:10.1111/jocn.13612 .
doi: 10.1111/jocn.13612:10.1111/jocn.13612
pubmed: 27706875
Rullo JE, Foxen JL, Griffin JM, Geske JR, Gonzalez CA, Faubion SS, et al. Patient acceptance of sexual orientation and gender identity questions on intake forms in outpatient clinics: a pragmatic randomized multisite trial. Health Serv Res. 2018;53(5):3790–808. https://doi.org/10.1111/1475-6773.12843:10.1111/1475-6773.12843 .
doi: 10.1111/1475-6773.12843:10.1111/1475-6773.12843
pubmed: 29522236
pmcid: 6153164
Rosser BRS, Polter EJ, Chandiramani N, Cahill S, Wheldon CW, Konety BR, et al. Acceptability and feasibility of collecting sexual orientation and expanded gender identity data in urology and oncology clinics. LGBT Health. 2021;8(6):420–6. https://doi.org/10.1089/lgbt.2020.0256:10.1089/lgbt.2020.0256 .
doi: 10.1089/lgbt.2020.0256:10.1089/lgbt.2020.0256
pubmed: 34348045
pmcid: 8591059
Alexander K, Walters CB, Banerjee SC. Oncology patients’ preferences regarding sexual orientation and gender identity (sogi) disclosure and room sharing. Patient Educ Couns. 2020;103(5):1041–8. https://doi.org/10.1016/j.pec.2019.12.006:10.1016/j.pec.2019.12.006 .
doi: 10.1016/j.pec.2019.12.006:10.1016/j.pec.2019.12.006
pubmed: 31862127
Carpentier MY, Tiro JA, Savas LS, Bartholomew LK, Melhado TV, Coan SP, et al. Are cancer registries a viable tool for cancer survivor outreach? A feasibility study. J Cancer Surviv. 2013;7(1):155–63. https://doi.org/10.1007/s11764-012-0259-1:10.1007/s11764-012-0259-1 .
doi: 10.1007/s11764-012-0259-1:10.1007/s11764-012-0259-1
pubmed: 23247719
Mangold KN, Gallicchio L, Gaysynsky A, Kent EE, Constantine K, Hesse BW. Feasibility of collecting patient-generated health data to enhance cancer registry surveillance. J Cancer Surviv. 2021;15(5):785–91. https://doi.org/10.1007/s11764-020-00970-z:10.1007/s11764-020-00970-z .
doi: 10.1007/s11764-020-00970-z:10.1007/s11764-020-00970-z
pubmed: 33400151
Paul C, Courtney R, Sanson-Fisher R, Carey M, Hill D, Simmons J, et al. A randomized controlled trial of the effectiveness of a pre-recruitment primer letter to increase participation in a study of colorectal screening and surveillance. BMC Med Res Methodol. 2014;14:44. https://doi.org/10.1186/1471-2288-14-44:10.1186/1471-2288-14-44 .
doi: 10.1186/1471-2288-14-44:10.1186/1471-2288-14-44
pubmed: 24690533
pmcid: 3975453
Hall AE, Sanson-Fisher RW, Lynagh MC, Threlfall T, D’Este CA. Format and readability of an enhanced invitation letter did not affect participation rates in a cancer registry-based study: a randomized controlled trial. J Clin Epidemiol. 2013;66(1):85–94. https://doi.org/10.1016/j.jclinepi.2012.07.016:10.1016/j.jclinepi.2012.07.016 .
doi: 10.1016/j.jclinepi.2012.07.016:10.1016/j.jclinepi.2012.07.016
pubmed: 23102853
Katapodi MC, Duquette D, Yang JJ, Mendelsohn-Victor K, Anderson B, Nikolaidis C, et al. Recruiting families at risk for hereditary breast and ovarian cancer from a statewide cancer registry: a methodological study. Cancer Causes Control. 2017;28(3):191–201. https://doi.org/10.1007/s10552-017-0858-2:DOI:10.1007/s10552-017-0858-2 .
Brick JMWD. Explaining rising nonresponse rates in cross-sectional surveys. Ann Am Acad Pol Soc Sci. 2013;645(1):36–59. https://doi.org/10.1177/0002716212456834:10.1177/0002716212456834 .
doi: 10.1177/0002716212456834:10.1177/0002716212456834
Galea S, Tracy M. Participation rates in epidemiologic studies. Ann Epidemiol. 2007;17(9):643–53. https://doi.org/10.1016/j.annepidem.2007.03.013:10.1016/j.annepidem.2007.03.013 .
doi: 10.1016/j.annepidem.2007.03.013:10.1016/j.annepidem.2007.03.013
pubmed: 17553702
Morton LM, Cahill J, Hartge P. Reporting participation in epidemiologic studies: a survey of practice. Am J Epidemiol. 2006;163(3):197–203. https://doi.org/10.1093/aje/kwj036:10.1093/aje/kwj036 .
doi: 10.1093/aje/kwj036:10.1093/aje/kwj036
pubmed: 16339049
Stedman R, Connelly NA, Heberlein TA, Decker DJ, Allred SB. The end of the (research) world as we know it? Understanding and coping with declining response rates to mail surveys. Soc Nat Resour. 2019;32(10):1139–54. https://doi.org/10.1080/08941920.2019.1587127:10.1080/08941920.2019.1587127 .
doi: 10.1080/08941920.2019.1587127:10.1080/08941920.2019.1587127
Dutwin D, Lavrakas P. Trends in telephone outcomes, 2008–2015. Surv Pract. 2016;9(3):1–9. https://doi.org/10.29115/SP-2016-0017:10.29115/SP-2016-0017 .
doi: 10.29115/SP-2016-0017:10.29115/SP-2016-0017
Lunn MR, Capriotti MR, Flentje A, Bibbins-Domingo K, Pletcher MJ, Triano AJ, et al. Using mobile technology to engage sexual and gender minorities in clinical research. PloS One. 2019;14(5):e0216282. https://doi.org/10.1371/journal.pone.0216282:10.1371/journal.pone.0216282 .
doi: 10.1371/journal.pone.0216282:10.1371/journal.pone.0216282
pubmed: 31048870
pmcid: 6497300
Boehmer U, Clark M, Glickman M, Timm A, Sullivan M, Bradford J, et al. Using cancer registry data for recruitment of sexual minority women: successes and limitations. J Womens Health (Larchmt). 2010;19(7):1289–97. https://doi.org/10.1089/jwh.2009.1744:10.1089/jwh.2009.1744 .
doi: 10.1089/jwh.2009.1744:10.1089/jwh.2009.1744
pubmed: 20575681
Boehmer U, Clark MA, Timm A, Glickman M, Sullivan M. Comparing sexual minority cancer survivors recruited through a cancer registry to convenience methods of recruitment. Womens Health Issues. 2011;21(5):345–52. https://doi.org/10.1016/j.whi.2011.03.003:10.1016/j.whi.2011.03.003 .
doi: 10.1016/j.whi.2011.03.003:10.1016/j.whi.2011.03.003
pubmed: 21703869
Feldman JM, Waterman PD, Coull BA, Krieger N. Spatial social polarisation: using the index of concentration at the extremes jointly for income and race/ethnicity to analyse risk of hypertension. J Epidemiol Community Health. 2015;69(12):1199–207. https://doi.org/10.1136/jech-2015-205728:10.1136/jech-2015-205728 .
doi: 10.1136/jech-2015-205728:10.1136/jech-2015-205728
pubmed: 26136082
Krieger N, Waterman PD, Spasojevic J, Li W, Maduro G, Van Wye G. Public health monitoring of privilege and deprivation with the index of concentration at the extremes. Am J Public Health. 2016;106(2):256–63. https://doi.org/10.2105/AJPH.2015.302955:10.2105/AJPH.2015.302955 .
doi: 10.2105/AJPH.2015.302955:10.2105/AJPH.2015.302955
pubmed: 26691119
pmcid: 4815605
Bureau of Labor Statistics. National occupational employment and wage estimates, May 2015. [updated July 19, 2022]. https://www.bls.gov/oes/tables.htm . Accessed August 1, 2022.
Bureau of Labor Statistics. Employer costs for employee compensation historical listing, national compensation survey. 2021 [updated September 2021]. https://www.bls.gov/web/ecec/ececqrtn.pdf . Accessed August 1, 2022.
Cohen J. Statistical power analysis for the behavioral sciences. 2nd ed. Hilsdale, NJ: Lawrence Erlbaum Associates; 1988.
Vacha-Haase T, Thompson B. How to estimate and interpret various effect sizes. J Counsel Psychol. 2004;51(4):473–81. https://doi.org/10.1037/0022-0167.51.4.473:10.1037/0022-0167.51.4.473 .
doi: 10.1037/0022-0167.51.4.473:10.1037/0022-0167.51.4.473
Amrhein V, Greenland S, McShane B. Scientists rise up against statistical significance. Nature. 2019;567(7748):305–7. https://doi.org/10.1038/d41586-019-00857-9:10.1038/d41586-019-00857-9 .
doi: 10.1038/d41586-019-00857-9:10.1038/d41586-019-00857-9
pubmed: 30894741
Wasserstein RL, Schirm AL, Lazar NA. Moving to a world beyond “p < 0.05.” Am Stat. 2019;73(sup1):1–19. https://doi.org/10.1080/00031305.2019.1583913:10.1080/00031305.2019.1583913 .
doi: 10.1080/00031305.2019.1583913:10.1080/00031305.2019.1583913
Gold MRSJ, Russell LB, Weinstein MC. Cost-effectiveness in health and medicine. New York, NY: Oxford University Press; 1996.
Millar MM, Elena JW, Gallicchio L, Edwards SL, Carter ME, Herget KA, et al. The feasibility of web surveys for obtaining patient-reported outcomes from cancer survivors: a randomized experiment comparing survey modes and brochure enclosures. BMC Med Res Methodol. 2019;19(1):208. https://doi.org/10.1186/s12874-019-0859-9:10.1186/s12874-019-0859-9 .
doi: 10.1186/s12874-019-0859-9:10.1186/s12874-019-0859-9
pubmed: 31730474
pmcid: 6858678
Ford ME, Sterba KR, Bearden JD 3rd, Gansauer L, Moore LA, Zapka J. Recruiting colorectal cancer survivors to a surveillance study: barriers and successful strategies. Patient Educ Couns. 2017;100(3):526–33. https://doi.org/10.1016/j.pec.2016.10.006:10.1016/j.pec.2016.10.006 .
doi: 10.1016/j.pec.2016.10.006:10.1016/j.pec.2016.10.006
pubmed: 28277291
Brajcich BC, Palis BE, McCabe R, Nogueira L, Boffa DJ, Lum SS, et al. Twenty-five years of cancer follow-up; is the data worth the effort? Ann Surg Oncol. 2022;29(2):828–36. https://doi.org/10.1245/s10434-021-10668-w:10.1245/s10434-021-10668-w .
doi: 10.1245/s10434-021-10668-w:10.1245/s10434-021-10668-w
pubmed: 34689251
Ilich AI, Danilak M, Kim CA, Mulder KE, Spratlin JL, Ghosh S, et al. Effects of gender on capecitabine toxicity in colorectal cancer. J Oncol Pharm Pract. 2016;22(3):454–60. https://doi.org/10.1177/1078155215587345:10.1177/1078155215587345 .
doi: 10.1177/1078155215587345:10.1177/1078155215587345
pubmed: 26002954
Kim SE, Paik HY, Yoon H, Lee JE, Kim N, Sung MK. Sex- and gender-specific disparities in colorectal cancer risk. WJG. 2015;21(17):5167–75. https://doi.org/10.3748/wjg.v21.i17.5167:10.3748/wjg.v21.i17.5167 .
doi: 10.3748/wjg.v21.i17.5167:10.3748/wjg.v21.i17.5167
pubmed: 25954090
pmcid: 4419057
Klein SL, Morgan R. The impact of sex and gender on immunotherapy outcomes. Biol Sex Differ. 2020;11(1):24. https://doi.org/10.1186/s13293-020-00301-y:10.1186/s13293-020-00301-y .
doi: 10.1186/s13293-020-00301-y:10.1186/s13293-020-00301-y
pubmed: 32366281
pmcid: 7197158
Millar MM, Kinney AY, Camp NJ, Cannon-Albright LA, Hashibe M, Penson DF, et al. Predictors of response outcomes for research recruitment through a central cancer registry: evidence from 17 recruitment efforts for population-based studies. Am J Epidemiol. 2019;188(5):928–39. https://doi.org/10.1093/aje/kwz011:10.1093/aje/kwz011 .
doi: 10.1093/aje/kwz011:10.1093/aje/kwz011
pubmed: 30689685
pmcid: 6494669
Kent EE, Arora NK, Rowland JH, Bellizzi KM, Forsythe LP, Hamilton AS, et al. Health information needs and health-related quality of life in a diverse population of long-term cancer survivors. Patient Educ Couns. 2012;89(2):345–52. https://doi.org/10.1016/j.pec.2012.08.014:10.1016/j.pec.2012.08.014 .
doi: 10.1016/j.pec.2012.08.014:10.1016/j.pec.2012.08.014
pubmed: 23021856
pmcid: 4560240
Kamen CS, Pratt-Chapman ML, Meersman SC, Quinn GP, Schabath MB, Maingi S, et al. Sexual orientation and gender identity data collection in oncology practice: findings of an ASCO survey. JCO Oncol Pract. 2022;18(8):e1297–305. https://doi.org/10.1200/OP.22.00084:10.1200/OP.22.00084 .
doi: 10.1200/OP.22.00084:10.1200/OP.22.00084
pubmed: 35605183
pmcid: 9377687
Maragh-Bass AC, Torain M, Adler R, Schneider E, Ranjit A, Kodadek LM, et al. Risks, benefits, and importance of collecting sexual orientation and gender identity data in healthcare settings: a multi-method analysis of patient and provider perspectives. LGBT Health. 2017;4(2):141–52. https://doi.org/10.1089/lgbt.2016.0107:10.1089/lgbt.2016.0107 .
doi: 10.1089/lgbt.2016.0107:10.1089/lgbt.2016.0107
pubmed: 28221820
Myers KJ, Jaffe T, Kanda DA, Pankratz VS, Tawfik B, Wu E, et al. Reaching the “hard-to-reach” sexual and gender diverse communities for population-based research in cancer prevention and control: methods for online survey data collection and management. Front Oncol. 2022;12:841951. https://doi.org/10.3389/fonc.2022.841951:10.3389/fonc.2022.841951 .
doi: 10.3389/fonc.2022.841951:10.3389/fonc.2022.841951
pubmed: 35756657
pmcid: 9213655